** U.S.-listed shares of Belgian medical device maker Nyxoah NYXH.BR, NYXH.O fall ~15% to $9.63
** Co says U.S. FDA has issued an "Approvable Letter" for Genio system to treat moderate to severe sleep apnea
** Obstructive sleep apnea patients stop breathing briefly while sleeping
** FDA issues approvable letters when it classifies a device as approved, pending information such as review of manufacturing
** Piper Sandler analyst Adam Maeder says the update "derisks" U.S. regulatory approval process
** Says approval and launch expected to be delayed by about 1-2 quarters, but revenue impact to be "negligible in the bigger picture"
** Co was expecting approval by the end of 1Q25
** NYXH fell 16.4% in the last 12 months
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))